Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.49 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.49 |
| ▸ | TDP2 | O95551 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6637788 | 0.92 | CTRB1 (0.48) | ELANECTRB1TDP2NPC1RAB9A | |
| SCHEMBL6722616 | 0.90 | CTRB1 (0.48) | ELANECTRB1TDP2P2RX7TSHR | |
| SCHEMBL6639120 | 0.89 | CTRB1 (0.47) | ELANECTRB1TDP2P2RX7TSHR | |
| SCHEMBL6401408 | 0.88 | CTRB1 (0.54) | ELANECTRB1TDP2P2RX7TSHR | |
| SCHEMBL6637372 | 0.86 | ELANE (0.53) | ELANECTRB1TDP2P2RX7TSHR | |
| SCHEMBL6637376 | 0.85 | CTRB1 (0.49) | ELANECTRB1TDP2TSHREGFR | |
| SCHEMBL6639534 | 0.84 | CTRB1 (0.41) | ELANECTRB1TSHRNPC1RAB9A | |
| SCHEMBL6637170 | 0.83 | CTRB1 (0.40) | ELANECTRB1TSHRNPC1RAB9A | |
| SCHEMBL6634617 | 0.83 | CTRB1 (0.47) | ELANECTRB1P2RX7NPC1RAB9A | |
| SCHEMBL6639603 | 0.83 | CTRB1 (0.50) | ELANECTRB1TDP2P2RX7TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | claimed |
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |